Literature DB >> 15096481

Bruton's tyrosine kinase (Btk) enhances transcriptional co-activation activity of BAM11, a Btk-associated molecule of a subunit of SWI/SNF complexes.

Masayuki Hirano1, Yuji Kikuchi, Sazuku Nisitani, Akiko Yamaguchi, Atsushi Satoh, Taiji Ito, Hideo Iba, Kiyoshi Takatsu.   

Abstract

Bruton's tyrosine kinase (Btk) is required for B cell development and signal transduction through cell-surface molecules such as BCR and IL-5 receptor. We have identified a Btk-associated molecule, BAM11 (hereafter referred to as BAM) that binds to the pleckstrin homology (PH) domain of Btk, and inhibits Btk activity both in vivo and in vitro. In this study, we demonstrate BAM's transcriptional co-activation activity and its functional interaction with Btk. By using transient transcription assays, we demonstrate that the enforced expression of BAM enhances transcriptional activity of the synthetic reporter gene. The C-terminus of BAM is essential for the transcriptional co-activation activity. The ectopic expression of Btk together with BAM enhances BAM's transcriptional co-activation activity. BAM's transcriptional co-activation activity is enhanced through interaction with Btk, and requires both its intact PH domain and functional kinase activity. We also show that enforced expression of TFII-I, another Btk-binding protein with transcriptional activity, together with BAM and Btk, further augments BAM- and Btk-dependent transcriptional co-activation. Furthermore, BAM can be co-immunoprecipitated with the INI1/SNF5 protein, a member of the SWI/SNF complex that remodels chromatin and activates transcription. We propose a model in which Btk regulates gene transcription in B cells by activating BAM and the SWI/SNF transcriptional complex via TFII-I activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096481     DOI: 10.1093/intimm/dxh076

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.

Authors:  Jaya Rajaiya; Jamee C Nixon; Neil Ayers; Zana P Desgranges; Ananda L Roy; Carol F Webb
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 2.  Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later.

Authors:  Ananda L Roy
Journal:  Gene       Date:  2011-10-21       Impact factor: 3.688

3.  Role of Bruton's tyrosine kinase inhibitors in HIV-1-infected cells.

Authors:  Irene Guendel; Sergey Iordanskiy; Gavin C Sampey; Rachel Van Duyne; Valerie Calvert; Emanuel Petricoin; Mohammed Saifuddin; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  J Neurovirol       Date:  2015-02-12       Impact factor: 2.643

4.  Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Authors:  Jaya Rajaiya; Melissa Hatfield; Jamee C Nixon; David J Rawlings; Carol F Webb
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.

Authors:  Jamee C Nixon; Scott Ferrell; Cathrine Miner; Athenia L Oldham; Ute Hochgeschwender; Carol F Webb
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 6.  Interleukin-5 and IL-5 receptor in health and diseases.

Authors:  Kiyoshi Takatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

7.  New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing.

Authors:  Elena Doménech; Gonzalo Gómez-López; Daniel Gzlez-Peña; Mar López; Beatriz Herreros; Juliane Menezes; Natalia Gómez-Lozano; Angel Carro; Osvaldo Graña; David G Pisano; Orlando Domínguez; José A García-Marco; Miguel A Piris; Margarita Sánchez-Beato
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

8.  A critical role of the Thy28-MYH9 axis in B cell-specific expression of the Pax5 gene in chicken B cells.

Authors:  Toshitsugu Fujita; Fusako Kitaura; Hodaka Fujii
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

Review 9.  Targeting Bruton's tyrosine kinase in B cell malignancies.

Authors:  Rudi W Hendriks; Saravanan Yuvaraj; Laurens P Kil
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.